Briefing
Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Recruiting phase 2 trial modulating therapy for locally advanced nasopharyngeal carcinoma based on plasma EBV DNA level after induction chemotherapy (planned n=198).
- Design: Phase 2 · Recruiting